Resultados de la búsqueda 21-30 of 10546 for Lymphopenia
This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
Rochester, Minn. The purpose of this study is to explore how using different terms (with or without the word cancer) to identify papillary thyroid cancer might ...
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) is a type of slow-growing lymphoma. The name often is shortened to MALT lymphoma.
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Descripción general. Anaplastic large cell lymphoma (ALCL) is a type of lymphoma. Lymphoma is cancer that affects the lymphatic system.
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
clbemp-bu;="3ccm999od,Column--e="32x3hdf25.707 13.707L4.t.)ochevrmp-b//ta-cmplayer="{&quwida14 -atp://ta-c.wida14 f/spau/espuwida14 -atp://ta-c.wida14 ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?